The BRAF gene mutation plays a pivotal role in tumorigenesis, tumor development, and prognosis across various cancer types, including malignant melanoma, colon cancer, NSCLC, thyroid papillary carcinoma, and serous ovarian cancer. This evidence concerns the gene BRAF and differentiated thyroid carcinoma.